By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kamada Ltd. 

Kibbutz Beit Kama M.P.

Negev    85325  Israel
Phone: 07-991-2082 Fax: 07-991-2083




Company News
Kamada Ltd. (KMDA) Announces Extension Of GLASSIA® Supply And Distribution Agreement With Shire (SHPG) With Minimum $237 Million Of Revenue For The Years 2017 To 2020 10/6/2016 7:12:18 AM
Kamada Ltd. (KMDA) To Present A Corporate Overview At The Rodman & Renshaw 18th Annual Investment Conference 9/9/2016 7:34:27 AM
Kamada Ltd. (KMDA) And Kedrion Seek FDA Approval Of Human Rabies Immunoglobulin As A Post-Exposure Treatment 9/1/2016 11:13:01 AM
Kamada Ltd. (KMDA) Meets Primary Endpoint Of U.S. Phase II Study Of Inhaled Alpha-1 Antitrypsin For The Treatment Of Alpha-1 Antitrypsin Deficiency 8/30/2016 8:04:34 AM
Kamada Ltd. (KMDA) Reports Financial Results For The Second Quarter And First Six Months Of 2016 8/2/2016 8:32:56 AM
Shire (SHPG) And Kamada Ltd. (KMDA) Announce FDA Approval Of Expanded Label For Self-Infusion Of GLASSIA For The Treatment Of Emphysema Due To Severe AAT Deficiency 6/15/2016 11:28:02 AM
Kamada Ltd. (KMDA)’s Alpha-1 Antitrypsin Now Available To Treat Graft-Versus-Host Disease On MyTomorrows Early Access Platform 5/25/2016 10:13:27 AM
Kamada Ltd. (KMDA) Reports 2016 First Quarter Financial Results 5/9/2016 10:49:35 AM
Kamada Ltd. (KMDA) To Host First Quarter Financial Results Conference Call On May 9, 2016 At 8:30 Am Eastern Time 5/4/2016 10:58:04 AM
Kamada Ltd. (KMDA) Receives Two Milestone Payments Under Strategic Agreements With Chiesi Farmaceutici SpA And Baxalta (BXLT) 5/2/2016 9:48:17 AM